CrushSCI.com
121.9Average days
103.5Median days
2Fastest days
288Longest days
462025 publications

Paper Review Records

All Paper Review Records

18 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

259 days

Systemic purinergic dysregulation in melanoma revealed by soluble P2RX4 receptor fragments

Authors
Roland Martin Teras; Jyri Teras; Igor Kuprijanov; Caroline Khaddaj; Adriana Kalmõkova; Liisi Karlep; Ago Samoson; Lauri Toom; Airi Rump; Sirje Rüütel BoudinotShow moreShow less
Affiliations
1. East Tallinn Central Hospital, Tallinn, Estonia; 2. North Estonia Medical Centre, Tallinn, Estonia; 3. Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia; 4. Department of Cybernetics, Tallinn University of Technology, Tallinn, Estonia; 5. NMR Laboratory, Institute of Chemistry, University of Tartu, Tartu, EstoniaShow moreShow less
Source PDF DOI Publisher page
153 days

Pharmacological melatonin induces mitochondrial dysfunction and alters extracellular nucleotide metabolism and CD39/CD73 expression in human melanoma cells

Authors
Bruna Cristina Ozelame; Daiane Mânica; Gilnei Bruno da Silva; Andreia Machado Cardoso; Margarete Dulce Bagatini; Aline MânicaShow moreShow less
Affiliations
1. Post-Graduate Program in Health Sciences, Community University of the Region of Chapecó (UNOCHAPECÓ), Chapecó, Brazil; 2. Postgraduate Program in Biochemistry, Federal University of Santa Catarina (UFSC), Florianópolis, Brazil; 3. Multicenter Postgraduate Program in Biochemistry and Molecular Biology, State University of Santa Catarina (UDESC), Lages, Brazil; 4. Post-Graduate Program in Biomedical Sciences, Federal University of Fronteira Sul, Chapecó, BrazilShow moreShow less
Source PDF DOI Publisher page
109 days

Targeting the P2X7 receptor in Alzheimer’s disease: mechanistic insights and emerging therapeutic strategies

Authors
Maida Engels SE; Anandhi RamalingamShow moreShow less
Affiliations
1. Department of Pharmaceutical Chemistry, PSG College of Pharmacy, Coimbatore, India; 2. Department of Pharmacology, PSG College of Pharmacy, Coimbatore, IndiaShow moreShow less
Source PDF DOI Publisher page
64 days

Targeting P2Y 14 R inhibits proliferation of cervical cancer cells and organoids and activates cAMP/PKA/CREB signaling pathway

Authors
Rui Li; Hai-Yun Xiong; Shi-Yu Chen; Yong Tang; Wen-Bin MaShow moreShow less
Affiliations
1. International Joint Research Centre On Purinergic Signalling, School of Health and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, China; 2. Sichuan Science City Hospital, Mianyang, ChinaShow moreShow less
Source PDF DOI Publisher page
145 days

P2X7 receptor gene polymorphisms in atherosclerosis patients classified based on angiographic stenosis grading

Authors
Süleyman Ince; Ahu Soyocak; Funda Seher Özalp Ateş; Emrah ErmişShow moreShow less
Affiliations
1. Institute of Graduate Studies, Master’s Program in Molecular Medicine, Istanbul Aydın University, Istanbul, Türkiye; 2. Faculty of Medicine, Department of Medical Biology, Istanbul Aydın University, Istanbul, Türkiye; 3. Faculty of Medicine, Department of Biostatistics and Medical Informatics, Manisa Celal Bayar University, Manisa, Türkiye; 4. Faculty of Medicine, Department of Cardiology, Istanbul Aydın University, Istanbul, TürkiyeShow moreShow less
Source PDF DOI Publisher page
156 days

ATP is not always pro-inflammatory: rethinking purinergic signalling in cancer and autoimmunity

Authors
Mohamed S. Nafie; Mohamed K. DiabShow moreShow less
Affiliations
1. Department of Chemistry, College of Sciences, University of Sharjah, Sharjah, United Arab Emirates; 2. Bioinformatics and Functional Genomics Research Group, Research Institute of Sciences and Engineering (RISE), University of Sharjah, Sharjah, United Arab Emirates; 3. Department of Chemistry, Faculty of Science, Suez Canal University, Ismailia, Egypt; 4. Pest Physiology Department, Plant Protection Research Institute, Agricultural Research Center, Giza, EgyptShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Purinergic Signalling take to review a manuscript?

As of 2026-11-19, CrushSCI has 18 complete review records for Purinergic Signalling. The fastest paper went from submission to acceptance in 2 days (Antagonism of P2X7 receptor function in synovial fibroblasts is a potential therapeutic manipulation in rheumatoid arthritis, received 2026-08-30, accepted 2026-09-01); the slowest took 288 days. The average is 121.9 days and the median is 103.5 days. The fastest record has an unusually short interval; please check the original source.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.